GTC
Ghost Tree Capital’s Crinetics Pharmaceuticals CRNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $7.67M | Sell |
150,000
-90,000
| -38% | -$4.6M | 2.32% | 14 |
|
|
2024
Q2 | $10.7M | Buy |
240,000
+40,000
| +20% | +$1.79M | 3.37% | 7 |
|
|
2024
Q1 | $9.36M | Buy |
200,000
+135,000
| +208% | +$6.32M | 2.59% | 9 |
|
|
2023
Q4 | $2.31M | Sell |
65,000
-36,443
| -36% | -$1.3M | 0.76% | 31 |
|
|
2023
Q3 | $3.02M | Buy |
+101,443
| New | +$3.02M | 0.99% | 24 |
|
|
2022
Q2 | – | Sell |
-85,000
| Closed | -$1.87M | – | 33 |
|
|
2022
Q1 | $1.87M | Sell |
85,000
-33,344
| -28% | -$732K | 0.4% | 31 |
|
|
2021
Q4 | $3.36M | Sell |
118,344
-31,656
| -21% | -$899K | 1.2% | 30 |
|
|
2021
Q3 | $3.16M | Sell |
150,000
-93,309
| -38% | -$1.96M | 0.92% | 37 |
|
|
2021
Q2 | $4.59M | Buy |
+243,309
| New | +$4.59M | 1.26% | 28 |
|